A Randomized, Open-Label, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Zolpidem Modified Release (MR) in Patients With Primary Insomnia.

Trial Profile

A Randomized, Open-Label, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Zolpidem Modified Release (MR) in Patients With Primary Insomnia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2011

At a glance

  • Drugs Estazolam; Zolpidem
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 05 Oct 2011 Actual end date (November 2010) added as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Nov 2010 Planned End Date changed from 1 Dec 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top